Degrees and Certifications

• Ph.D., Health Policy (Economics), Harvard University, Cambridge, MA (2011)
• M.A., Economics, University of Toronto, Toronto, ON (2001)
• B.Sc., Mathematics and Economics, University of Toronto, Toronto, ON (2000)

Positions and Employment

Academic Appointments

• 2019-present: Assistant Professor, Department of Economics, Wayne State University
• 2019-present: Assistant Professor, Department of Pharmacy Practice, Wayne State University
• 2011-2019: Assistant Professor, Department of Public Health Sciences, University of Chicago

• 2022-: Project Collaborator, Transformative Research in Urban Sustainability Training (T-RUST), Wayne State University
• 2020-: Member, Barbara Ann Karmanos Cancer Institute
• 2012-2019: Faculty Affiliate, Center for Health and the Social Sciences, University of Chicago
• 2012-2019: Member, University of Chicago Comprehensive Cancer Center

• 2014- present: Alliance for Clinical Trials in Oncology: Member of Cancer Care Delivery Research, Symptom Intervention, Health Outcomes, Prevention, Community Oncology, Health Disparities, and Cancer in the Older Adult Committees

Professional Memberships

• 2018-present: International Society for Pharmacoeconomics and Outcomes Research
• 2018-present: Society for Medical Decision Making
• 2014-present: American Society of Clinical Oncology
• 2011, 2015, 2018-present: American Economic Association
• 2008-present: American Society of Health Economists

Primary Research Interest

Fabrice Smieliauskas is a health economist in the Department of Economics and the Department of Pharmacy Practice at Wayne State University. His economic and health services research on pharmaceuticals and medical devices in cancer and surgery addresses questions requiring a cross-disciplinary marriage of rigorous economic methods with biological and clinical knowledge. This work falls under three main themes: 1) determining the costs and value of medical technologies and procedures; 2) advancing the field of implementation science in health care; 3) analyzing the effects of public policy and regulation on the biomedical research enterprise.

Recent Publications

Refereed Journal Articles

• Navari, R.M., J. Le-Rademacher, F. Smieliauskas, K.J. Ruddy, T.J. Saphner, H. Liu, B. Harlos, A.A. Onitilo, K. Giridhar, P.P. Singh, P.S. Reddy, F. Kluter, G. Raptis, C.L. Loprinzi. In Press. Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (Alliance A221602). The Oncologist. https://academic.oup.com/oncolo/advance-article/doi/10.1093/oncolo/oyad140/7191652.

• Sharma, H., F. Smieliauskas. 2022. Malnutrition Inequality Between Dalits and Non-Dalits in Nepal – A Decomposition Analysis. World Development. 159:106040. https://www.sciencedirect.com/science/article/pii/S0305750X22002303.

• Salloum, R.G., H. D’Angelo, R. Theis, B. Rolland, D. Pauk, S. Hohl, J. LeLaurin, Y. Asvat, L-S Chen, A. Day, A. Goldstein, B. Hitsman, D. Hudson, A. King, C. Lam, A. Levinson, J. Prochaska, F. Smieliauskas, K. Lenhoff, K. Taylor, J. Thomas, H. Tindle, E. Tong, J.S. White, B. Vogel, G. W. Warren, M. Fiore. 2021. Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers. Implementation Science Communiations 2(1):41. https://implementationsciencecomms.biomedcentral.com/articles/10.1186/s43058-021-00144-7.

• Press, D.J., B. Aschebrook-Kilfoy, D. Lauderdale, E. Stepniak, S. Gomez, E. Peterson Johnson, R. Gopalakrishnan, F. Smieliauskas, D. Hedeker, L. Bettencourt, L. Anselin, H.Ahsan. 2021. ChicagO Multiethnic Prevention And Surveillance Study (COMPASS): increased response rates among African American residents in low socioeconomic status neighborhoods. Journal of Racial and Ethnic Disparities 8(1):186-198. https://link.springer.com/article/10.1007/s40615-020-00770-2.

• Witiw, C. D., F. Smieliauskas, S. Ham, V.C. Treynelis. 2020. Cervical Disc Replacement: “Real-world” Utilization of an Emerging Technology. Journal of Neurosurgery: Spine 32(5):689-695. https://thejns.org/view/journals/j-neurosurg-spine/aop/article-10.3171.

• Uppal, A., F. Smieliauskas, S. Maron, M. Sharma, B. Polite, M.C. Posner, K. Turaga. 2020. Facilities that Service Economically Advantaged Neighborhoods Perform Surgical Metastasectomy More Often for Patients with Colorectal Liver Metastases. Cancer. 126(2):281-292. https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32529.

• Sharma, H., R.T. Konetzka, F. Smieliauskas. 2019. The Relationship Between Reported Staffing and Expenditures in Nursing Homes. Medical Care Research and Review. 76(2):758-783. http://journals.sagepub.com/doi/10.1177/1077558717739214.

• Dong, J., F. Smieliauskas, R. T. Konetzka. 2019. Effects of Long-Term Care Insurance on Financial Well-being. The Geneva Papers on Risk and Insurance – Issues and Practice. 44(2):277-302. https://link.springer.com/article/10.1057/s41288-018-00113-7. 

• Pandey, K.R., F. Yang, K.A. Cagney, F. Smieliauskas, D.O. Meltzer, G.W. Ruhnke. 2019. The impact of marital status on health care utilization among Medicare beneficiaries. Medicine. 98(12):e14871. https://insights.ovid.com/pubmed?pmid=30896632.

• Witiw, C. D., F. Smieliauskas, J. O’Toole, M. Fehlings, R. Fessler. 2019. Comparison of anterior cervical discectomy and fusion to posterior cervical foraminotomy for cervical radiculopathy: utilization, costs and adverse events 2003 – 2014. Neurosurgery. 84(2):413-420. https://academic.oup.com/neurosurgery/article/84/2/413/4934773.

Research Funding

Current

• 8/19-7/25: NCI UG1 CA189823. PI: J. Buckner. My role: co-I. “Alliance NCORP Research Base”. 
• 12/18–11/23: NCI R01 CA225647. PI: Y.-C. T. Shih. My role: co-I. “Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors, and Economic Implications”. 
• 11/17–3/20: NCI P30 CA014599. PI: M. Le Beau. My role: co-I. “No Smoker Left Behind.”

Past

• 9/14–6/19: NCI UG1 CA189823. PI: J. Buckner. My role: co-I. “Alliance NCORP Research Base”. 
• 3/16–1/18: NCATS UL1 TR000430. PI: F. Smieliauskas. My role: PI. “A Comparison of Single Level Anterior Cervical Discectomy and Fusion to Posterior Cervical Foraminotomy in the Treatment of Cervical Radiculopathy: A National Perspective with Long Term Follow-up.” 
• 1/16–12/17: CHAS Seed Award. PI: F.Smieliauskas. My role: PI. “Racial disparities in Predictive Biomarkers, Access to Precision Medicine, and Cancer Outcomes”. 
• 4/14–3/16: NCI R03 CA184986. PI: F. Smieliauskas. My role: PI. “Capacity constraints and disparities in the scale-up of lung cancer CT screening”. 
• 1/13–6/15: Cancer Research Foundation Young Investigator Award. PI: F. Smieliauskas. My role: PI. Title: "Off-label Drug Use in Oncology: Policy, Unintended Consequences, and Comparative Effectiveness". 
• 8/13–7/14: AHRQ R01 HS018535. PI: Y.-C. T. Shih. My role: Co-Investigator. Title: “Monoclonal Antibodies in Cancer Care: Is Underinsurance an Access Barrier?”. 
• 12/12–2/14: ACS #IRG 58-004. PI: F. Smieliauskas. My role: PI. Title: "Off-label drug use in oncology: policy and unintended consequences for clinical research". 
• 12/11–11/12: ACS #IRG 58-004. PI: F. Smieliauskas. My role: PI. Title: "The role of sponsorship in clinical oncology research: evidence from clinicaltrials.gov". 
• 5/11–4/14: NIH U01 GM087729. PI: D. Lauderdale. My role: Co-Investigator. Title: “Modeling MRSA in the Community”. 
• 7/07–6/10: NIH T32 AG00186. PI: D. Wise. My role: Pre-Doctoral Fellow in Health & Aging at the National Bureau of Economic Research. 
• 9/07–8/09: SSHRC Doctoral Fellowship.
• 9/05–8/06: AHRQ T32 HS000055. PI: J. Newhouse. My role: Doctoral Fellow.  

Departmental / University Service

• 2023: Reviewer, Social Sciences Research Support Program
• 2022-present: Project Collaborator, T-RUST (Transformative Research in Urban Sustainability Training) program
• 2021-present: Graduate Committee, Department of Economics
• 2020-present: Budget Committee, Department of Economics
• 2022: Economics Chair Charge Review Committee, Department of Economics
• 2021-2022: Salary Committee, Department of Economics
• 2019-2021: Undergraduate Committee, Department of Economics2019-present: Undergraduate Committee, Department of Economics, Wayne State University 

Editor / Reviewer

• 2019-present: Editorial Board, Medical Care Research and Review
• 2014: Full grant proposal reviewer, Robert Wood Johnson Foundation’s (RWJF) Public Health Services and Systems Research (PHSSR) program
• 2010-present: Referee for Journal of Health Economics, Pharmacoeconomics, Value in Health, Health Services Research, Medical Care Research and Review, Journal of the National Cancer Institute, Journal of the National Cancer Institute: Spectrum, The Oncologist, Journal of General Internal Medicine, Management Science 

Courses taught by Fabrice Smieliauskas

Fall Term 2024 (future)

• PPR6570 - Pharmaceutical Economics
• ECO5560 - Pharmaceutical Economics
• ECO6560 - Pharmaceutical Economics

Winter Term 2024 (current)

• ECO6020 - Causal Inference and Research Practice

Fall Term 2023

• PPR5155 - Social Administrative Sciences and Professional Development III: Practice Management
• PPR6570 - Pharmaceutical Economics
• ECO5560 - Pharmaceutical Economics
• ECO6560 - Pharmaceutical Economics

Winter Term 2023

• ECO5560 - Pharmaceutical Economics
• ECO6560 - Pharmaceutical Economics

Fall Term 2022

• PPR5155 - Social Administrative Sciences and Professional Development III: Practice Management

Winter Term 2022

• ECO6020 - Causal Inference and Research Practice

← Return to listing